Latest AI and machine learning research in metabolic syndrome for healthcare professionals.
Hypertension is a major risk factor for cardiovascular diseases. This study proposes a novel hypertension screening framework based on awake-sleep differences in photoplethysmography (PPG) indices, using machine learning. We hypothesised that normotensive individuals exhibit greater PPG variation between awake and sleep states than unmanaged hypertensive individuals. The Aurora-BP dataset (n=180; ...
Alzheimer’s disease (AD) is a complex neurodegenerative disorder with limited therapeutic options. The original DeepDrug framework by Li et al. (2025) relied on somatic mutation data and emphasized long genes to guide AD drug repurposing. However, emerging evidence suggests that germline genetic variants play a more central role in AD pathogenesis. In response, we develop DeepDrug2, an enhanced AI...
Left ventricular diastolic dysfunction (LVDD) is most commonly evaluated by echocardiography. However, without a sole identifying metric, LVDD is asse...
Dementia, especially Alzheimer’s disease (AD), is a major global health challenge marked by progressive cognitive impairment, behavioral changes, and ...
Target Trial Emulation (TTE) has emerged as a rigorous framework for causal inference using observational data, but its application in hypertension re...
Clinical practice guidelines recommend cardiovascular toxicity risk restratification including evaluation of new cardiovascular risk factors and cardi...
Inadequate pharmacologic stress may limit the diagnostic and prognostic accuracy of myocardial perfusion imaging (MPI). The splenic ratio (SR), a meas...
With rapid urbanization, lifestyle changes, and an aging population, non-communicable diseases (NCDs), including hypertension and diabetes, pose signi...
Accurate identification of direct causal (parental) variables for a target is of primary interest in many applications, especially in biomedical scien...
In cardiovascular magnetic resonance (CMR), myocardial native T1 mapping enables quantitative, non-invasive tissue characterization and is sensitive t...
Preterm birth, defined as birth occurring before 37 weeks of gestation, poses a significant and enduring public health challenge, with substantial emo...
Medication non-adherence remains a significant challenge in managing chronic conditions like diabetes and hypertension, leading to increased morbidity...
Hepatic steatosis (HS) is a common cardiometabolic risk factor frequently present but under-diagnosed in patients with suspected or known coronary art...
Although artificial intelligence–enhanced electrocardiography (AI-ECG) has shown promise in detecting cardiac abnormalities, large-scale validation ag...
Determination of cardiac output (CO) is essential to the clinical management of cardiovascular compromise. However, the invasiveness, procedural risks...
Stroke is one of the leading causes of death and long-term disability globally. Several studies have investigated the incidence and predictors of stro...
Development of anti-drug antibodies (ADAs) is a barrier to long-term efficacy of biologic therapies in rheumatoid arthritis (RA), but no biomarkers ex...
OSA and MetS have a bidirectional relationship but increasing evidence suggests metabolic heterogeneity in OSA, systematic phenotyping of metabolic dr...
White adipose tissue dysfunction has emerged as a critical factor in cardiometabolic disease development, yet the cellular microstructure and genetic ...
Bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH) are leading causes of morbidity and mortality in premature infants. To determine whet...